Susan has nearly 20 years of senior regulatory affairs experience with specialty pharmaceutical companies. Before joining Strongbridge, Susan was vice president, regulatory affairs, at Antares Pharma, where she served as a key contributor for the submission, approval, and launch of the company’s first commercialized product. Prior, she held roles of increasing responsibility at Aptalis Pharma, Inc.; Barrier Therapeutics; and Teva Pharmaceuticals USA. Her development and postapproval product experience includes gastroenterology, rheumatology, dermatology, urology, biologics, generics, and devices.   Susan has nearly 20 years of senior regulatory affairs experience with specialty pharmaceutical companies. Before joining Strongbridge, Susan was vice president, regulatory affairs, at Antares Pharma, where she served as a key contributor for the submission, approval, and launch of the company’s first commercialized product. Prior, she held roles of increasing responsibility at Aptalis Pharma, Inc.; Barrier Therapeutics; and Teva Pharmaceuticals USA. Her development and postapproval product experience includes gastroenterology, rheumatology, dermatology, urology, biologics, generics, and devices.

General Science